Scott Kollins is Holmusk's Chief Medical Officer. Before Holmusk, Scott spent more than 20 years as a faculty member at Duke University in the Department of Psychiatry & Behavioral Sciences, where he led an NIH and industry-funded clinical research program focused on ADHD. Scott has deep experience in clinical trial design and regulatory aspects for both traditional and digital therapeutics.
